Ambite, Ines http://orcid.org/0000-0003-1470-671X
Butler, Daniel http://orcid.org/0000-0002-6717-545X
Wan, Murphy Lam Yim
Rosenblad, Therese
Tran, Thi Hien
Chao, Sing Ming
Svanborg, Catharina
Article History
Accepted: 7 May 2021
First Online: 15 June 2021
Competing interests
: Patents have been filed for the use of the NlpD protein and <i>IRF7</i> siRNA as immune modulators and for the use of IL-1R antagonists in the treatment of cystitis. The rights to develop these patents are held by SelectImmune Pharma, where the scientists I.A., D.B., T.H.T., M.L.Y.W. and C.S. hold shares. T.R. and S.M.C. declare no competing interests.
Free to read: This content has been made available to all.